Demographics and knowledge of cervical cancer of female civil servants in Delta State on Nigeria

Background: Delta state of Nigeria is a typical micro-world of multicultural values and religious beliefs as well as socioeconomic strata that could impact on the uptake of cervical cancer screening and HPV vaccination. Yet, the demographics of women in conjunction with knowledge and perception of cervical cancer screening have not been surveyed. This study aimed to assess the demographics of civil service women servants in Delta State and their knowledge regarding cervical cancer.Methods: The study was a questionnaire-based cross-sectional survey of female civil servants in the states’ capital city of Asaba. Structured questionnaire was used to collect data on eight demographic factors (age, educational level, ethnicity, income level, marital status, number of children, religion and workplace); as well as information on knowledge of cervical. Percentage proportions of respondents were assessed for the eight demographic factors. Absolute frequencies of affirmative responses to the questions on knowledge were evaluation. Hypothesis was tested for statistical significance of the demographic variables.Results: Analysis of the respondents (N=285) show that virtually all participants have heard of cervical cancer and knows that sexual promiscuity is a risk of the health condition. Only less than 5% of them attribute healthcare workers as their source of knowledge. Except age and marital status, every demographic variable is significant (p<0.05).Conclusions: Demographics of women are significant in terms of potential factors that could influence the uptake of HPV vaccination and cervical cancer screening.

Download Full-text

Psycho-Social Factors Influencing Cervical Cancer Screening and Human Papilloma Virus Vaccination Acceptance Among Female Civil Servants in Delta State, Nigeria

Journal of Global Oncology ◽

10.1200/jgo.18.47800 ◽

2018 ◽

Vol 4 (Supplement 2) ◽

pp. 21s-21s ◽

Cited By ~ 1

Author(s):

B. Ohaeri ◽

P. Ebunu ◽

C. Ndikom

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Human Papilloma Virus ◽

Cervical Cancer Screening ◽

Social Factors ◽

Hpv Vaccination ◽

Civil Servants ◽

Sub Saharan Africa ◽

Screening Tests ◽

Papilloma Virus

Background: Cervical cancer is the fourth most common cancer affecting women worldwide and most notable in low and middle income countries of sub-Saharan Africa. There are 528000 new cases estimated globally every year. The crude incidence rate of cervical cancer is 5.8% worldwide, 19% in West Africa, and 19.3% in Nigeria. In Nigeria, uptake of cervical cancer screening and HPV vaccination has been demonstrated in different studies to be very low, out of thirteen studies, nine show cervical cancer screening uptake of less than 5.3%. Psycho-social factors such as anxiety, stigmatization, poor health seeking behaviors and lack of family and social support among others, have been implicated. Therefore, this study assessed the psycho-social barriers to utilization of cervical cancer screening services and uptake of vaccination among female civil servants in Delta state. Aim: To assess the psycho-social factors that impede the utilization of cervical cancer screening and HPV vaccination among female civil servants in Delta state. Methods: A descriptive, cross-sectional, nonexperimental design was used for this study. Multi-stage sampling technique was used in selecting 437 women who consented, based on a calculated sample size. Thereafter, 437 self-administered structured questionnaires with a reliability coefficient of 0.7, were administered to participants, out of which 435 were retrieved. This gave a response rate of 99.5%. Data collected were analyzed with the aid of Statistical Package for Social Sciences (SPSS) using descriptive statistics and χ2. Results: Many participants (55.4%) knew about cervical cancer; 93.6% had never been screened for cervical cancer, while 94.7% had not vaccinated their teenage girls against human papilloma virus. Among the psycho-social factors highlighted that impeded the utilization of services were, costs of the screening tests (54.5%) and HPV vaccine (51.3%), while 58.2% reported inaccessibility. However, majority (73.6%) were willing to go for the cervical cancer screening and vaccination of their teenagers (68%). Conclusion: Cervical cancer screening and subsequent vaccination are strategies focused at ensuring reduction in the incidence of cervical cancer in the society to the barest minimum. Creating awareness about cervical cancer could be a means to help tackle the lack of knowledge issue, thereby increasing knowledge. In addition, subsidization will go a long way in lessening the financial burden, as well as increase utilization. Subsequently, global burden of cervical cancer will be reduced, with a consequent reduction in mortality.

Download Full-text

Determinants of Cervical Cancer Screening Uptake among Women in Ilorin, North Central Nigeria: A Community-Based Study

Journal of Cancer Epidemiology ◽

10.1155/2016/6469240 ◽

2016 ◽

Vol 2016 ◽

pp. 1-8 ◽

Cited By ~ 15

Author(s):

Ajibola Idowu ◽

Samuel Anu Olowookere ◽

Aderonke Tolulope Fagbemi ◽

Olumuyiwa Ayotunde Ogunlaja

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Statistical Significance ◽

Effective Control ◽

Bivariate Analysis ◽

North Central ◽

Nigerian Women ◽

Screening Uptake ◽

Cancer Of The Cervix

Introduction. Cancer of the cervix is the leading cause of cancer deaths among women in developing countries. Screening is one of the most cost effective control strategies for the disease. This study assessed the determinants of cervical cancer screening uptake among Nigerian women.Methodology. This cross-sectional study was conducted using multistage sampling technique among 338 participants in Ilorin, North Central Nigeria. A pretested questionnaire was used for data collection and data analysis was done using SPSS version 21. Chi-square test was used for bivariate analysis while binary logistic regression was used for multivariate analysis. Statistical significance was set atp<0.05.Results. Only 8.0% of the respondents had ever been screened for cancer of the cervix. The proportion of women who had ever been screened was significantly higher among those who demonstrated positive attitude to screening (81.5%,p=0.001), respondents who were aware of the disease (100.0%,p=0.001), and those who were aware of cervical cancer screening (88.9%,p=0.001). Respondents who had negative attitude had 63% lesser odds of being screened compared to those who had positive attitudes towards screening (AOR; 0.37, 95% CI; 0.01–0.28).Conclusion. There is urgent need to improve the knowledge base and attitude of Nigerian women to enhance cervical cancer screening uptake among them.

Download Full-text

The Pittsburgh Cervical Cancer Screening Model: A Risk Assessment Tool

Archives of Pathology & Laboratory Medicine ◽

10.5858/134.5.744 ◽

2010 ◽

Vol 134 (5) ◽

pp. 744-750

Author(s):

R. Marshall Austin ◽

Agnieszka Onisko ◽

Marek J. Druzdzel

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Disease Risk ◽

Hpv Vaccination ◽

Dynamic Bayesian Network ◽

Adenocarcinoma In Situ ◽

Test Results ◽

Hpv Test

Abstract Context.—Evaluation of cervical cancer screening has grown increasingly complex with the introduction of human papillomavirus (HPV) vaccination and newer screening technologies approved by the US Food and Drug Administration. Objective.—To create a unique Pittsburgh Cervical Cancer Screening Model (PCCSM) that quantifies risk for histopathologic cervical precancer (cervical intraepithelial neoplasia [CIN] 2, CIN3, and adenocarcinoma in situ) and cervical cancer in an environment predominantly using newer screening technologies. Design.—The PCCSM is a dynamic Bayesian network consisting of 19 variables available in the laboratory information system, including patient history data (most recent HPV vaccination data), Papanicolaou test results, high-risk HPV results, procedure data, and histopathologic results. The model's graphic structure was based on the published literature. Results from 375 441 patient records from 2005 through 2008 were used to build and train the model. Additional data from 45 930 patients were used to test the model. Results.—The PCCSM compares risk quantitatively over time for histopathologically verifiable CIN2, CIN3, adenocarcinoma in situ, and cervical cancer in screened patients for each current cytology result category and for each HPV result. For each current cytology result, HPV test results affect risk; however, the degree of cytologic abnormality remains the largest positive predictor of risk. Prior history also alters the CIN2, CIN3, adenocarcinoma in situ, and cervical cancer risk for patients with common current cytology and HPV test results. The PCCSM can also generate negative risk projections, estimating the likelihood of the absence of histopathologic CIN2, CIN3, adenocarcinoma in situ, and cervical cancer in screened patients. Conclusions.—The PCCSM is a dynamic Bayesian network that computes quantitative cervical disease risk estimates for patients undergoing cervical screening. Continuously updatable with current system data, the PCCSM provides a new tool to monitor cervical disease risk in the evolving postvaccination era.

Download Full-text

Peer Review #1 of "Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in León, Nicaragua (v0.1)"

10.7287/peerj.3871v0.1/reviews/1 ◽

2017 ◽

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Peer Review ◽

Cervical Cancer Screening ◽

Rural Women ◽

Hpv Vaccination ◽

Knowledge And Beliefs

Download Full-text

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing

Viruses ◽

10.3390/v10120729 ◽

2018 ◽

Vol 10 (12) ◽

pp. 729 ◽

Cited By ~ 42

Author(s):

Andreas Chrysostomou ◽

Dora Stylianou ◽

Anastasia Constantinidou ◽

Leondios Kostrikis

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Hpv Vaccination ◽

Screening Method ◽

Population Based ◽

Screening Tests ◽

Screening Methods ◽

Hpv Testing ◽

Screening Programs

Cervical cancer is the fourth most frequently occurring cancer in women around the world and can affect them during their reproductive years. Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cases, HPV molecular screening tests and HPV vaccines for primary prevention against the virus have been developed. Accordingly, comparative studies were designed to assess the performance of cervical cancer screening methods in order to devise the best screening strategy possible. This review critically assesses the current cervical cancer screening methods as well as the implementation of HPV vaccination in Europe. The most recent European Guidelines and recommendations for organized population-based programs with HPV testing as the primary screening method are also presented. Lastly, the current landscape of cervical cancer screening programs is assessed for both European Union member states and some associated countries, in regard to the transition towards population-based screening programs with primary HPV testing.

Download Full-text

Impact of the Current US Preventive Services Task Force Recommendations for Cervical Cancer Screening in Young Women 21 to 29 Years Old

American Journal of Clinical Pathology ◽

10.1093/ajcp/aqaa012 ◽

2020 ◽

Vol 153 (6) ◽

pp. 734-742 ◽

Cited By ~ 2

Author(s):

C Paul Morris ◽

Sayanan Chowsilpa ◽

Sara Mustafa ◽

Isaac Chan ◽

Daniel Miller ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Task Force ◽

Statistical Significance ◽

Academic Medical Center ◽

Tertiary Care ◽

Preventive Services ◽

High Grade ◽

The Impact

Abstract Objectives In 2012, the US Preventive Services Task Force decreased the recommended frequency of cervical cytology screening to once every 3 years and recommended against testing women younger than 21 years regardless of sexual history. We evaluated the impact of this in 21 to 29-year-old women at a tertiary care academic medical center in 2011 and 2017. Methods We retrospectively analyzed Papanicolaou test results at two time points in 21- to 29-year-old women. Results There was a decrease in the number of high-grade lesions in 21- to 25-year-old women (odds ratio [OR], 0.36) from 2011 to 2017. Within the 26- to 29-year-old patient group, there was a trend toward a higher percentage of high-grade squamous intraepithelial lesion (HSIL) in 2017 compared to 2011 on cytology, which did not reach statistical significance (OR, 1.46). However, follow-up histologic specimens showed a higher percentage of HSIL in 2017 compared to 2011 in this age group (OR, 2.16). Conclusions Our findings suggest that the cervical cancer screening guidelines introduced in 2012 have not had a detrimental impact on the outcomes of cervical cancer screening for 21- to 25-year-old women. However, we need to continue monitoring the effects of decreased screening in 26- to 29-year-old women.

Download Full-text